newsfilter
← Latest News
PR Newswire·

Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364

Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has...